|Emitents||Grindeks, AS (5299006DWR32NKWM1O86)|
|Veids||2.2. Iekšējā informācija|
According to the interview with Chairman of the Council of JSC “Grindeks” Kirovs Lipmans, published by National information agency LETA on 14 May 2019, JSC “Grindeks” confirms that in five years JSC “Grindeks” could reach 300 million euro turnover.
JSC “Grindeks” informs that in 2018 its subsidiary JSC “Kalceks” has distributed medications for 10,1 million euro. This year JSC “Kalceks” is planning to sell its pharmaceutical products for nearly 19 million euro. JSC “Kalceks” is planning to maintain this growth rate in the next five years.